Sacituzumab govitecan User Reviews & Ratings
Brand names: Trodelvy
Sacituzumab govitecan has an average rating of 8.0 out of 10 from a total of 2 reviews on Drugs.com. 100% of reviewers reported a positive experience, while 0% reported a negative experience.
| Condition | Avg. Rating | Reviews | Compare |
|---|---|---|---|
| Breast Cancer | 2 reviews for Breast Cancer | 76 medications | |
| Add your review | |||
- Elle...
- February 5, 2024
Trodelvy (sacituzumab govitecan) for Breast Cancer "Other than neutropenia and alopecia, my side effects are minimal. I'm in the middle of my treatment plan, still hopeful that this will give me a sustained remission."
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
More about sacituzumab govitecan
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español
Trodelvy (sacituzumab govitecan) for Breast Cancer "I occasionally have slurred speech and difficulty swallowing. It's kind of intermittent. No other side effect except complete alopecia"